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Laminins (LMs) are important structural proteins of the extracellular matrix 
(ECM). The abundance of every LM isoform is tissue-dependent, suggesting 
that LM has tissue-specific roles. LM binds growth factors (GFs), which are 
powerful cytokines widely used in tissue engineering due to their ability to 
control stem cell differentiation. Currently, the most commonly used ECM 
mimetic material in vitro is Matrigel, a matrix of undefined composition 
containing LM and various GFs, but subjected to batch variability and lacking 
control of physicochemical properties. Inspired by Matrigel, a new and com-
pletely defined hydrogel platform based on hybrid LM-poly(ethylene glycol) 
(PEG) hydrogels with controllable stiffness (1–25 kPa) and degradability is 
proposed. Different LM isoforms are used to bind and efficiently display GFs 
(here, bone morphogenetic protein (BMP-2) and beta-nerve growth factor 
(β-NGF)), enabling their solid-phase presentation at ultralow doses to specifi-
cally target a range of tissues. The potential of this platform to trigger stem 
cell differentiation toward osteogenic lineages and stimulate neural cells 
growth in 3D, is demonstrated. These hydrogels enable 3D, synthetic, defined 
composition, and reproducible cell culture microenvironments reflecting the 
complexity of the native ECM, where GFs in combination with LM isoforms 
yield the full diversity of cellular processes.
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and structural proteins such as LM and 
fibronectin (FN) that also provide func-
tionality.[1] These two proteins, in par-
ticular, play an important role in ECM 
architecture, cell-adhesion, and binding 
of numerous molecules, thus influencing 
cell behavior. They are also involved in 
matrix remodeling and, therefore, tissue 
homeostasis. Their important contribu-
tion to ECM structure and function has 
inspired rigorous research efforts focused 
on recreating these properties in vitro.
Currently, the most commonly used 
ECM mimetic material is Matrigel, an 
undefined mix of proteins and GFs 
derived from Engelbreth–Holm–Swarm 
mouse sarcoma cells that provide excellent 
biological functionality.[2] However, batch-
to-batch variation, suboptimal mechanical 
properties, and undefined composition of 
animal origin make it difficult to deter-
mine the exact signals that promote cell 
function and make it unsuitable for trans-
lation to clinic. There have been many 
unsuccessful attempts to produce an alter-
native synthetic, defined, culture system that recapitulates the 
properties of the natural ECM and therefore Matrigel is still 
widely used for in vitro 3D cell culture.[3] To reproduce the ECM 
properties in a synthetic system, it is key to incorporate struc-
tural proteins such as LM and FN, combined with GFs that play 
an essential role in many cellular processes.[4] That the ECM 
acts as a GF reservoir[5] and the GF contribution to cell adhe-
sion and function is almost totally overlooked in synthetic gel 
culture systems where adhesion peptides remain a focus and 
suboptimal performance, remains a challenge.
LMs are multimeric glycoproteins, formed of three chains α, 
β, and γ, and located mainly in the basement membrane (BM).[6] 
They have an important role in cell differentiation, proliferation, 
and migration.[7,8] There are sixteen isoforms of LM with tissue-
dependent distribution.[6] These include LM332, predominantly 
found in epithelial, bone, and vascular tissues;[9,10] LM411 and 
LM111 in the central and peripheral nervous system (CNS 
and PNS);[11,12] as well as LM221 and LM521 that are mostly 
expressed in muscle[13,14] and liver,[15] respectively. Furthermore, 
as well as having tissue-dependent isoforms, different LMs have 
1. Introduction
The ECM forms the niche for tissue residing cells. It is made 
of a myriad of components including water, polysaccharides, 
© 2021 The Authors. Advanced Functional Materials published by Wiley-
VCH GmbH. This is an open access article under the terms of the Cre-
ative Commons Attribution License, which permits use, distribution and 
reproduction in any medium, provided the original work is properly cited.
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affinity for different GFs, making them a promising tool in the 
repair and regeneration of a variety of tissues.[4] Alternative 
mRNA splicing of LMs produces different isoforms whose 
abundance is tissue-dependent and have the ability to bind dif-
ferent GFs, making them a more versatile candidate than FN, 
that only has two different isoforms.[16]
GFs are potent, small cytokines capable of inducing cell dif-
ferentiation and tissue development. These molecules are widely 
used in basic and translational research. However, their short 
half-life, high diffusion coefficient, and cost makes their use 
in clinic challenging.[17,18] Currently, clinical administration of 
these molecules involves the use of high doses that have unde-
sired, systemic side effects such as ectopic bone formation and 
the development of malignant neoplasms.[19] Several strategies 
for GF delivery have been explored in recent years,[17,20] including 
their presentation covalently bound to biomaterials,[21,22] 
and non-covalently bound to peptides that contain domains 
with affinity for GFs.[23–25]
For example, binding of BMP-2, vascular endothelial growth 
factor A (VEGF-A), platelet-derived growth factor (PDGF-AB), 
and insulin-like growth factor 1 (IGF-1) to fibrin matrices.[26–30] 
Solid-phase presentation of GFs that are non-covalently bound 
to biomaterials involve the use of peptides that contain domains 
with affinity for GFs.[23–25]
Another strategy has exploited the affinity of GFs to certain 
protein sequences, for example, the heparin binding domain in 
FN (III12-14) or the α chain of LM, to produce fibrin hydrogels 
combined with these sequences.[31] For example, the LM-derived 
peptide LAMA33043–3067 was incorporated into fibrin gels and 
loaded with VEGF-A165 and PDGF-BB to improve skin wound 
healing of full-thickness.[9] Further, the affinity of VEGF-A and 
PDGF-BB to the α chain of LM was increased by coupling them 
to a syndecan-derived peptide (RKRLQVQLSIRT).[32]
Here, we present an approach that makes use of full-length 
LMs, using well-defined LM isoforms that bind GFs and target 
specific tissues, a strategy not considered in the literature so 
far.[9,33–35] For example, hydrogels functionalized with full-
length LM111 take advantage of its multiple bioactive domains 
that bind components of the basal membrane such as nidogen, 
perlecan, agrin, and collagen IV to enhance nervous tissue regen-
eration (neurite growth and neural stem cell (NSC) differentia-
tion).[33,36–40] However, there are no studies that exploit the affinity 
of different GFs to various LM isoforms and their involvement in 
the organisation of different tissues. Moreover, LM may possess 
other domains that play a relevant role in the in vivo physiology of 
the cells, which cannot be mimicked in a short synthetic peptide 
and will still be functional when using the full-length protein. Fur-
thermore, using full-length ECM proteins contributes to a better 
recapitulation of the ECM microenvironment and a stronger bio-
logical effect than with the use of shorter peptides.[41]
In this work, we present a strategy to develop LM/PEG-
based hydrogels that enhance the bioactivity and stability of 
GFs using selected LM isoforms with specific affinity for GFs. 
This system closely mimics the native tissue environment both 
bio-chemically and mechanically. Its stiffness can be tuned to 
resemble a variety of tissues allowing a broad range of appli-
cations. We report the controlled, solid-phase presentation of 
physiological doses of GFs (here BMP-2 and β-NGF) bound to 
different LM isoforms. The developed platform can outperform 
current approaches to deliver tissue-specific GFs, promoting 
bone and nervous tissue regeneration.
2. Results and Discussion
2.1. 3D Hybrid Laminin Hydrogels with Controlled Degradability 
and Mechanical Properties
Different LM isoforms were incorporated into a synthetic PEG 
polymeric network using UV-triggered photo-polymerisation 
(Figure  1A,B,C).[34,35] Human LM isoforms 111, 521, 411, and 
332 were first PEGylated with a PEG-acrylate-succinimidyl 
(PEG-AC-SCM) via a N-hydroxysuccinimide (NHS) ester reac-
tion with the primary amines of the protein, forming a stable, 
covalent amide bond at pH 8.3 and releasing the NHS group 
(Figure 1C).[34,35] The degree of PEGylation for different LM:AC 
ratios was measured by tracking the reduction in primary 
amines after the reaction using a 2,4,6-trinitrobenzene sulfonic 
acid (TNBSA) assay, which indicated an increase in the LM 
degree of modification as the LM:AC ratio increased (Figure S1A, 
Supporting Information). Then, the bioactivity and cell adhe-
sion to LM PEGylated at different ratios (10, 25, and 500 mole-
cules of PEG-AC-SCM per molecule of LM, denoted as 1:10, 
1:25, and 1:500 throughout the paper), was tested using C2C12 
cells. LM PEGylated at a 1:25 ratio showed a similar adhesion 
and formation of actin filaments compared to native LM and 
better than any other LM PEGylation ratios (Figure S1B, Sup-
porting Information). This demonstrates that PEGylation at 
1:25 does not alter LM bioactivity.[34,37]
3D LM/PEG hydrogels were produced by mixing PEGylated 
LM (1:25) with a four-arm acrylate PEG and crosslinkers 
(either protease-degradable GCRDVPMSMRGGDRCG pep-
tide (VPM) or PEG-dithiol (PEG-2SH)) (Figure  1B,C). LM dis-
tribution within the LM/PEG hydrogels was evaluated using 
immunofluorescence, showing a homogeneous distribution of 
the protein, whereas PEG-only gels did not show any staining 
(Figure 1D and Figure S2, Supporting Information). An image 
of the LM/PEG hydrogel after polymerization and hydrogel 
network structure taken using scanning electronic microscopy 
(SEM) is shown in Figure 1E. Then, the swelling properties of 
the gels were assessed over 28 days. After 7 days, the swelling 
ratio reached a plateau that was maintained at least until day 28 
(Figure 1F and Figure S4B, Supporting Information) revealing 
the stability of the crosslinking process.
Cells are known to remodel their environment by the secre-
tion of matrix metalloproteases (MMPs).[42,43] Recently, cells 
have been shown to secrete ECM proteins pericellularly and/or 
physically remodel their microenvironment in 3D, even if they 
do not change cell morphology.[44] Hybrid LM/PEG hydrogels 
were designed with controlled degradability by using different 
VPM to PEG-AC ratios. VPM is a target sequence to several 
secreted proteases such as collagenase I. Therefore, hydrogel 
degradation will depend on the presence of cell-secreted MMPs. 
By varying the collagenase I concentration (10 and 30 U per ml), 
an enzyme that degrades LM and VPM, we observed that the 
degradation of 5% w/v LM521/PEG (AC:VPM, 2:1) depends on 
the collagenase concentration for the first 3 days. Then, data 
suggest that the hydrogels start to degrade also hydrolytically 
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after 20 days (Figure  1G; and Figure S4A, Supporting 
Information).
Next, to adjust the mechanical properties of the hydrogel for 
the different applications intended, LM/PEG hydrogels with 
different amounts of 4-arm PEG-acrylate (PEG-AC) at a final 
concentration of 3.5%, 5%, and 10% w/v were crosslinked with 
different ratios of PEG-AC to protease-degradable VPM, namely 
AC:VPM: 2:1,1:1, or 1:2. Degradability and mechanical properties 
of the system can be controlled independently by altering the 
ratio of the AC to VPM. By increasing the amount of PEG-AC, 
we obtained hybrid LM/PEG-gels with controllable stiffness of ≈2, 
5, and 10  kPa, as measured by atomic force microscopy (AFM) 
and illustrated in Figure S3A, Supporting Information (left side). 
Since the amount of LM is tissue-dependent, we produced gels 
with different concentrations of LM while maintaining a constant 
stiffness (Figure S3A, right side, Supporting Information).[6] This 
Figure 1. LM hydrogels chemistry and physical characterisation. A) LM structure with hypothesized GF binding sites. B) Gel components: 4-arm PEG 
AC macromer, PEG-2SH, and VPM, a target sequence to several secreted proteases. C) LM/PEG gel formulation schematic drawing, where the first step 
presented is PEGylation, the reaction used to functionalise LM molecules with ACs at different ratios, followed by photopolymerisation, reaction used to 
crosslink the LM-PEG gel. D) Immunofluorescence images of laminin distribution in 3.5, 5 and 10% w/v LM111/PEG gel cryosections (scale bar 50 µm). 
Laminin was stained with a Cy3 secondary antibody, shown in red in the images. E) Picture showing a flat LM/PEG hydrogel after polymerisation and SEM 
picture of the hydrogel network. F) Wet mass loss of 10% w/v LM332/PEG hydrogels incubated for 28 days in basal culture medium (mean ± standard 
deviation (SD), n = 3, a two-way ANOVA with Geissner–Greenhouse correction and Tukey post-hoc test was used to compare the PEG ± VPM and LM/PEG 
± VPM data along the time series, with p values stated in the Supporting Information Table). Comparison between the samples within the same group are 
shown in Table S1G, Supporting Information. Degradation of LM521/PEG hydrogels with VPM (degradable gels) and SH (non-degradable gels) at AC:VPM 
or AC: SH ratio of 2:1 using 30 U per mL of collagenase type I (mean ± SD, n = 3, a two- way ANOVA test with a mixed-effects model to compensate for 
few missing values was performed between all the time points, followed by Tukey’s post-hoc multiple comparisons test with p values stated in Table S1, 
Supporting Information). Comparison between the samples within the same group are shown in the Supporting Information Table.
Adv. Funct. Mater. 2021, 2010225
www.afm-journal.dewww.advancedsciencenews.com
2010225 (4 of 14) © 2021 The Authors. Advanced Functional Materials published by Wiley-VCH GmbH
further corroborates the versatility of the system as stiffness can 
be controlled independently of the amount of LM or LM isoform.
To further expand the range of mechanical properties of the 
hydrogels, their composition was varied to achieve final con-
centrations of 12% and 15% w/v PEG (≈15kPa and 25kPa); and 
then crosslinking the network at 2:1 AC:VPM ratio. Mechanical 
properties of LM/PEG hydrogels were characterised by shear 
bulk rheology and nanoindentation (Figure 2A,C); these tech-
niques allow investigation of distinct aspects of the mechanical 
properties of hydrogels, due to i) the length scale at which they 
are performed (bulk vs nanoscale), ii) the nature of the meas-
urement (i.e., dynamic vs static), iii) the mode of deformation 
of the material (shear vs axial).[45]
Shear rheology measurements were performed to study the 
bulk viscoelastic (i.e., dynamic) properties of the gels which 
arise both from the intrinsic polymeric nature of the material as 
Figure 2. Mechanical Properties of LM/PEG hydrogels. A) Bulk rheology schematic (left side). The upper plate of radius R (7.5mm) oscillates at a 
constant frequency (10 rads-1) and increasing shear stress, τ, resulting in an increasing oscillatory strain γ (0.01 to 1%). The phase lag, δ, between 
the applied stress and the resulting strain defines the viscoelastic behavior of the sample. B) Bulk rheology results. Each bar reports the mean of five 
consecutive data points of a strain sweep performed in the LVE region of the material at gap size corresponding to an applied force of 0.1N. Error bars 
report mean ± SD, n = 1 per gel. For each gel, five points (n = 5) were taken from a strain sweep to calculate G’. Significance calculated using one-way 
ANOVA with Tukey multiple comparison to compare different percentages of PEG with/without LM where ****p < 0.0001. Comparison between PEG 
gels with/without laminin with the same PEG percentage are shown in Table S1C, Supporting Information. Schematic of a nanoindentation experiment 
(left side). A spherical tip of radius R (8 µm) indents the hydrogel – modeled as an elastic half space – with force F, inducing a deformation field of 
characteristic size a and depth δ. By fitting the Hertz solution to the forward curve of the F–δ relationship (represented by (a) in inset schematic graph); 
(b) is the retract curve of the F–δ relationship), the Young’s modulus is calculated (Equation (1) shown in Experimental Section). D) Nanoindentation 
results. In situ stiffness measurements of hydrogels loaded with hMSCs at 0, 1, and 9 days compared with an acellular sample measured after prepara-
tion at day 0 and 9 (mean ± SD, n > 22 curves, significance calculated using ANOVA with Tukey multiple comparison where ****p < 0.0001). E) Shows 
unimodal distribution of Young’s Modulus (normalised histograms and probability function estimations of modulus distribution), in accordance with 
the literature,[46] as explained in the main text.
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well as the high water content entrapped within the network.[46] 
Sufficiently robust bulk mechanical properties are essential to 
ensure material stability in vivo.[47] A frequency sweep was per-
formed prior to all experiments to determine the regime where 
the shear storage modulus, G’, was independent of frequency, 
ω, so that the shear modulus G of the gels could be measured 




).[48] Strain sweeps in the range of 0.01% to 1% at 
an angular frequency of 10 rad s–1, within the linear viscoelastic 
(LVE) regime of the gels, were performed and the shear mod-
ulus determined at a gap size corresponding to a normal force 
of ≈0.1 N (see Experimental Section for more details). Rheology 
results are reported as stiffness (Young’s modulus) throughout 
the manuscript to ease the comparison with nanoindentation 
(and AFM) results. The Young’s modulus, E, was obtained from 
shear modulus, G, following E G (1 )υ= + , where, υ  is the Pois-
son’s ratio, assumed to be 0.5 (incompressible material) given 
the highly hydrated nature of the gels. Results are reported in 
Figure 2B for PEG + SH and LM521/PEG + VPM gels with the 
same ratio AC:VPM (2:1). Variation of PEG-AC content at final 
concentration of 3.5, 5, 10, 12, and 15% w/v allowed us to pro-
duce a wide range of stiffnesses, from very soft gels suitable 
for 3D culture of neural cells, for example, ≈2  kPa for 3.5% 
w/v LM521/PEG degradable;[33,34,36,49] to stiff gels suitable for 
osteogenic differentiation of stem cells, for example, ≈25  kPa 
(and up to ≈80  kPa; Figure S3B, Supporting Information) for 
15% w/v LM521/PEG degradable.[45,50] The low frequency range 
and LVE regime of the measurements explain the increase in 
E with polymer concentration as a direct consequence of the 
increasing number of crosslinks in the network, following 
rubber elasticity theory,[48] and in accordance with PEG gels 
reported in literature.[51]
Establishing that the bulk mechanical properties of the 
hydrogels offer a wide range of physiologically relevant stiff-
nesses,[47] we moved on to investigate microscale properties 
of the gels which are important in the context of cell interac-
tions with the material. Nanoindentation measurements allow 
investigation of the static properties (i.e., Young’s modulus) of 
the gels at the microscale (see Figure 2C and Experimental Sec-
tion for more details). However, the ECM is a dynamic environ-
ment involving active tissue mechanics driven by cells. Here, 
we investigated the mechanical properties of hydrogels loaded 
with human mesenchymal stem cells (hMSCs) using protease-
degradable hydrogels (5% w/v LM521/PEG + AC:VPM (2:1) and 
demonstrate that a “biolabile” environment[47] permits cells to 
mechanically remodel their surroundings (Figure  2D). After 
9 days in culture, the hydrogels’ Young’s modulus decreased by 
almost ≈50%. This suggests that hMSC-secreted MMPs cleave 
the degradable linker (VPM), thus leading to softening of the 
surrounding cellular microenvironment by a degradation-
driven remodeling process. This is in accordance with recent 
literature,[44] where it was shown that sufficiently cross-linked 
hMSC-laden S-HA-PEGDA (“stiff” gels) exhibited a decrease in 
stiffness due to cell-driven matrix degradation; in contrast to 
weakly cross-linked gels (“soft” gels) where matrix deposition 
was dominant and led to an increase in hydrogel stiffness.
Our results are also in agreement with those of Ferreira 
et al.[44] in terms of Young’s Modulus distribution. The Young’s 
modulus is unimodally distributed when microenvironment 
remodeling is driven by degradation (as in this case, Figure 2E) 
whereas it takes on a bimodal profile when surrounding remod-
eling is driven by matrix deposition and therefore stiffening.[44] 
Matrix remodeling (i.e., both the deposition of a pericellular 
ECM and the degradation of the surrounding environment) is 
an important variable to consider in addition to initial mechan-
ical properties of the biomaterial[44,52–54] as it has been shown 
that matrix deposition and degradation are a variable control-
ling hMSC phenotype.[44]
To assess the biocompatibility of LM/PEG hydrogels, hMSCs 
were encapsulated in 5% w/v LM 521/PEG hydrogels with an 
AC:VPM ratio of 2:1 and cultured for 1, 3, and 7 days, followed 
by live/dead mammalian cytotoxicity/viability assay. hMSCs cul-
tured in 5% w/v LM521/PEG hydrogels showed viability values 
of approximately 75% after 7 days (Figure 3A; and Figure S5A, 
Supporting Information). Over the past few decades, cell mor-
phology in 3D has been shown to be influenced by stiffness, 
degradability rate, and ECM-protein concentration in the mate-
rial.[55,56] To evaluate whether the morphology of the cells is 
influenced by degradability rate, LM521/PEG gels at different 
ratios of AC:VPM (2;1,1;1,1:2) were loaded with hMSCs for 
7 days. Figure  3B; and Figure S5B, Supporting Information, 
show that cell morphology is similar for all the different degra-
dation ratios after 7 days, but cells are less rounded and display 
more protrusions per cells in the gel with higher degradability 
rate (e.g., 1:2 of AC:VPM ratio). The fact that the cell mor-
phology did not change with increasing degradability after day 7 
can be correlated to the hydrogel mesh size, as well as the chain 
growth polymerisation method used to prepare the hydrogel.[57]
These results agree with recent studies which showed that 
chain versus step-growth polymerizations impact cellular 
morphology and function.[58,59] The influence of the LM con-
tent on cell morphology was also studied. Gels with different 
concentrations of LM 521 (100 and 500  µg mL-1) were pre-
pared and compared with gels without LM521 after 7 days in 
culture. Our results indicate that LM521/PEG (2:1) hydrogels 
with different LM concentrations do not have an influence on 
hMSC morphology (Figure  3C; and Figure S5C, Supporting 
Information). This can be explained by the small mesh size of 
the hydrogels, which was calculated theoretically using hydro-
gels’ stiffness shown in Figure S6, Supporting Information. 
That MSCs in 3D hydrogels do not change their morphology 
due to a small mesh size is in agreement with the work of 
Huebsch et al.[60]
2.2. 3D LM332/PEG Hydrogels Loaded with BMP-2 Underpin  
In Vitro Osteogenesis
Different LM isoforms have different affinities for various GFs[9] 
and the abundance of every LM isoform is tissue dependent,[24] 
suggesting that LM has tissue-specific roles.[61] In this work, 
our aim is to use lower concentrations of GFs in solid-phase 
presentation in 3D environments with controlled mechanics 
and degradability. Concentrations used in vitro are typically in 
the range of 50 to 100 ng mL-1 for 2D cultures [62,63] and up to 
100 µg mL-1 in 3D cultures, specifically hydrogels.[64,65]
We first investigated whether BMP-2 loaded in LM332/PEG 
hydrogels is retained within the system as this LM isoform had 
shown a high affinity for BMP-2.[9] The GF-binding ability of 
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the hybrid LM332/PEG hydrogels was investigated by loading 
hydrogels with 5  µg mL-1 BMP-2 labeled with AlexaFluor-488 
dye. In Figure 4A, after 5 days, the release in 5% w/v LM332/
PEG and PEG-only hydrogels shows that the former retained up 
to 85% of the initial amount of BMP-2, while the retention in 
PEG-only gels was lower, around 70%. In the 10% w/v LM332/
PEG hydrogels, BMP-2 retention was similar to that seen at 5% 
w/v, whereas in 10% w/v PEG-only hydrogels, BMP-2 reten-
tion was slightly higher; 80% in the 10% w/v versus 70% in the 
5% w/v hydrogels. We hypothesise that the higher retention of 
BMP-2 in LM/PEG hydrogels is due to BMP-2 being bound to 
LM which recapitulates binding of GFs to the ECM and should 
result in stronger biological effects.[66] The observed retention 
of BMP-2 in PEG-only gels is likely due to the mesh size of 
the system, which leads to lower swelling of the hydrogel and 
less diffusion of BMP-2 over 5 days. We hypothesise that even if 
BMP-2 is sterically retained within the hydrogel, this is in “sol-
uble presentation”, that is, not bound to the ECM and so with 
lower biological activity.
Our release results are in accordance with the literature, 
where fibrin gels functionalized with heparin, which is known 
to bind GFs, were loaded with BMP-2 and retained 85% of the 
initial GF amount.[67] BMP-2-loaded collagen gels, that are cur-
rently the gold standard in vivo,[68] released 90% of their initial 
payload after 5 days. Overall, data suggests that BMP-2 binds to 
the full-length LM molecule crosslinked to the 3D PEG hydro-
gels, which can be produced with controllable stiffness and 
degradation rate. Moreover, LM ability to bind BMP-2 in a dose-
dependent manner was demonstrated by studying the release 
of BMP-2 at different concentrations (0.1, 1, and 5 µg mL-1) 
Figure 3. Cell viability and morphology of hMSCs in 3D LM/PEG hydrogels. A) Images of calcein (green) and ethidium (red) for hMSCs in 5% w/v 
LM521/PEG with 100µg mL-1 of LM521 at AC:VPM 2:1 and quantification of hMSCs viability in 5% w/v LM521/PEG hydrogels after 1, 3, and 7 days 
(scale bar 100 µm). The lowest viability values were found in the PEG+SH hydrogels, while in the LM/PEG gels, the viability values were higher than 
75% in each tested condition (mean ± SD, n = 3, significance calculated using one-way ANOVA with Tukey multiple comparison for samples within the 
same group with *p = 0.0219, ***p = 0.0004, ***p = 0.0001). Comparison between samples within different groups are shown in Table S1B, Supporting 
Information. Immunofluorescence images of the actin cytoskeleton (green) and nuclei (blue) for hMSCs in 5% w/v LM521/PEG with 100 µg mL-1 of 
LM 521 at different ratios of AC:VPM (2:1, 1:1, 1:2) (scale bar 50 µm) with a display of protrusion in the images by using a red arrow and quantification 
of cell area and circularity for those images and C) 5% w/v LM521/PEG at 2:1 ratio with various LM concentration (100 to 500 µg mL-1) compared with 
gels without LM after 7 days. Statistics are shown as mean ± SD, n = 5 images per condition from three different biological replicates (scale bar 50 µm). 
Data were analysed by an unpaired t-test, α = 0.05 with no statistically significant difference found between the samples with p > 0.05.
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from 10% w/v LM332/PEG over 5 days (see figure S7, Sup-
porting Information).
We next investigated the ability of hybrid LM332/PEG hydro-
gels to promote osteogenic differentiation of hMSCs. To test this 
hypothesis, hMSCs were embedded in 3D LM/PEG hydrogels 
loaded with 5  µg mL-1 BMP-2 and cultured for 14 and 21 days 
to assess their phenotype, in both basal and osteogenic media 
(OM). At initial loading, the amount of BMP-2 in a typical gel 
was 0.25 µg, after 5 days it was 0.22 µg. The molecular weight of 
LM332 is 619 kDa and is 26 kDa for the BMP-2 dimer. Thus, the 
stoichiometric ratio of BMP-2 to LM332 is initially ≈2 and ≈1.7 
after 5 days of release; the amount of BMP-2 loaded in the hydro-
gels used is enough to bind all the LM molecules in the system.
Figure  4B shows immunofluorescence images of hMSCs 
cultured for 14 days under basal and osteogenic conditions 
to evaluate the expression of the late osteogenic expression 
markers osteopontin (OPN, in red) and osteocalcin (OCN, in 
magenta). Detailed immunofluorescence images displayed 
in Figure  4B were added to Figure S8A, Supporting Infor-
mation, for better visualisation. To quantify the total surface 
volume and intensity of OPN and OCN expression for cells 
cultured for 14 days, 3D surface rendering of z-stacks with 
Imaris software was employed (see Experimental Section). 
It was observed that the presence of BMP-2 in LM332/PEG 
increased OPN expression to levels comparable to gels cul-
tured in osteogenic media (Figure 4C), without any effect on 
OCN expression after 14 days (Figure 4C). On the other hand, 
PEG-only gels loaded with BMP-2 showed lower expres-
sion of OPN and OCN compared to gels loaded with BMP-2 
and cultured in osteogenic media. These data demonstrate 
that the amount of soluble BMP-2 that remains trapped in 
the PEG network (PEG+VPM+BMP2) is not enough to pro-
mote osteogenic differentiation whereas the same amount of 
BMP-2 bound to LM is.
To confirm this, gene expression of osteogenic markers was 
also assessed by qRT-PCR. Results showed upregulated osteo-
pontin expression when compared to the gels cultured in oste-
ogenic media at 14 days (Figure  4D), as previously observed.[69] 
OPN and OCN expression were further evaluated after 21 days, 
indicating that OCN expression level did not show any statisti-
cally significant difference between the two tested conditions 
(Figure S8B, Supporting Information). The lack of statistical sig-
nificance in the mRNA expression values of OPN and OCN at 
21 days might be due to the temporal expression profile of both 
genes,[69] where OPN reaches a maximum around 14 days and 
then the expression is attenuated, whereas OCN shows a mono-
tonic increase in its expression values, reaching a maximum after 
21 days. Even if the amount of BMP-2 retained in the gel after 
5 days is similar (220 and 200 ng corresponding to LM/PEG and 
PEG), the biological effects of the BMP-2 bound to LM332 on the 
Figure 4. LM/PEG promotes hMSCs osteogenesis in 3D A) Cumulative 
release of fluorescently labeled BMP-2 with Alexa 488 (BMP-2-488), from 
5 and 10% w/v PEG and LM332/PEG hydrogels, loaded with 5 µg mL-1 
BMP-2-488 over 5days (mean ± SD, n = 3, ****p < 0.0001, Kruskal–Wallis 
and Dunn’s post hoc test). B) Immunofluorescence images of hMSCs 
cultured for 14 days in 10% w/v LM332/PEG in culture medium, under 
basal and differentiation conditions (osteogenic media-OM). Images 
show nuclei (blue), osteopontin (red), osteocalcin (magenta) (scale bar 
50  µm). C) 3D immunofluorescence quantification of osteopontin and 
osteocalcin from z-stack images (mean ± SD, n = 3,5 stacks per replicate) 
using Imaris. We have represented in the graph the Integrated density (total 
raw intensity per image normalised by cell area), rendered in 3D Imaris 
for each imaged volume. Significance calculated using one-way ANOVA 
with Tukey multiple comparison, where *p = 0.0116. D) Real-time qPCR 
analysis for markers of osteogenesis (OPN and OCN) after 14 days. Each 
condition was normalised to the osteogenic media (OM) (mean ± SD, 
n = 3, one-way ANOVA with Tukey multiple comparison, where **p = 0.0027, 
*p = 0.0236).
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hMSC differentiation are significantly different. We hypothesize 
that this effect is due to the synergistic effect between LM and 
BMP-2, as a result of a solid-phase presentation of BMP-2 bound 
to LM, compared to the effects of BMP-2 in “soluble” presenta-
tion. This results in hMSC phenotypic changes as demonstrated 
by immunofluorescence and qPCR (Figure 4B,C,D).
2.3. LM411/PEG Hydrogels Loaded with β-NGF Promote 3D 
Neurite Outgrowth
We investigated the capacity of LM411-based hydrogels to bind 
and present β-NGF to explanted dorsal root ganglion (DRG) 
cell cultures in a 3D environment. DRG cells are a cluster of 
neurons located in the dorsal root of the spinal nerve. Being 
afferent cells that carry sensory messages to the CNS, they are 
associated with neuropathic pain.[70] In particular, this neuron 
cluster is in charge of regulating important processes associated 
with nocioception and temperature sensing, inflammarion, and 
somatic pain as well as neuropathic pain (NP). These neurons 
are inherently involved in peripheral nerve injury repair and 
neurodegenerative disorder management as they bridge com-
munication between the PNS and CNS. Thus, it is important to 
restore nerve function and communication of the two systems 
in the case of traumatic injury or disease.
For this work, we explored the behaviour of explanted DRG 
cells from P1 rat pups (Figure 5A) when introduced to 3.5% w/v 
PEG+VPM, LM411/PEG+VPM and FN/PEG+VPM soft hydro-
gels, as they are better suited for neural regeneration applica-
tions,[34,49] with or without added GFs. The same concentration 
of LM and FN was incorporated in the PEG hydrogels (i.e., 
0.3 mg mL-1) in order to obtain an accurate comparison of their 
biological activity.
For stimulating neurite growth in DRG cultures, the LM411 
isoform was used as it is one of the two LMs (LM211 and LM411) 
expressed in peripheral nerves, and its growth-promoting quali-
ties for ganglion neurons after injury have previously been 
reported.[71] In the work of Plantman et  al., neurite growth on 
LM411 was said to be β-NGF dependent.[71] This is reasonable, 
considering that this β-NGF is heavily secreted by the periph-
eral nerve niche when injury occurs to promote local neuronal 
survival and axonal regrowth.[72] To asses the role of LM411 
hydrogels in driving neurite outgrowth, hydrogels prepared 
with another key ECM protein, FN, were also employed. In the 
past, FN has been used to promote Schwann cell response,[73] 
and these cells have known roles in providing axons of injured 
nerves with metabolic and trophic support.[74] The role of FN 
in promoting neurite extension in vitro in hydrogel substrates 
has long been established as this ECM protein is intrinsically 
linked with the adhesion of the cell to the surface. In the past, 
FN has shown to aid nerve fiber extension and regeneration 
in 2-hydroxymethylacrylate hydrogels (HEMA),[75] silk fibroin 
hydrogels,[76] and FN-patterned comb polymers, for example.[77]
To gain insights on whether our system could drive neu-
rite growth by efficiently presenting β-NGF via ECM proteins, 
the GF was introduced into the experimental system in two 
ways: within the hydrogel precursosrs before polymerisation 
(at a concentration of 1  µg mL-1) or dissolved in the media 
(at a concentration of 0.5  µg mL-1, media was changed every 
2 days). Explanted DRGs were cultured and fixed for immu-
nostaining at 7 days (Figure  5B); neurite extension was sub-
sequently assessed by the maximum number of neurites per 
sample (Nmax)[78] obtained with Neurite-J, an ImageJ plug-in 
(Figure 5C; and Figure S9, Supporting Information).
It was clearly observable that DRGs cultured in LM411/
PEG+VPM hydrogels with 1  µg mL-1 of β-NGF inside the gel 
(before polymerisation) showed the most neurite outgrowth. 
When compared to PEG+VPM hydrogels with β-NGF loaded 
inside the gel, LM411/PEG+VPM with β-NGF loaded inside the 
gel showed significant neurite outgrowth (Figure 5B); the same 
was seen with FN/PEG+VPM hydrogels with β-NGF inside the 
gel. Neurite outgrowth was also significantly greater when β-
NGF was introduced inside the gel before polymerisation, com-
pared to conditions with β-NGF added into the media; this is 
especially true of the LM411/PEG + VPM condition (p = 0.0002). 
This result suggests a role for LM in presenting β-NGF effi-
ciently to the cell, driving greater growth by binding and 
releasing β-NGF in a time-efficient manner, which propells 
greater neurite growth than when β-NGF is added to the media. 
Additionally, when contrasting the two ECM proteins, LM411/
PEG+VPM hydrogels showed an increased Nmax when com-
pared to FN/PEG+VPM (p  = 0.1527). Although not statistically 
significant (0.1527 > 0.05); these results still suggest a stronger 
role for LM411 in aiding neurite outgrowth than FN; this cor-
roborates previous literature that highlights the role of this ECM 
protein in driving greater neuron sprouting than FN.[79–81]
2.4. Outlook
We have developed a platform of engineered hydrogels that 
incorporate full-length LM within a synthetic polymer net-
work with controlled physico-chemical properties. Cells reside 
within the ECM, a collection of proteins, such as FN and LM, 
which plays an important role in guiding cell fate and providing 
mechanical support for cells. Critically, these proteins hold 
great potential in tissue engineering due to their ability not 
only to support cell adhesion but for their ability to bind a large 
range of GFs;[9,31] many hydrogels fail to recapitulate this key 
niche facet. These properties highlight the importance of incor-
porating full-length proteins in biomaterials aimed at tissue 
regeneration and repair applications.
In contrast to FN, that has only two isoforms, alternative 
mRNA splicing of LM can produce up to 16 isoforms whose 
abundance is tissue-dependent and in turn have the ability to 
bind different GFs, making them a more versatile candidate 
than FN. LMs influence cell differentiation, migration, and 
phenotype stability and inhibit apoptosis by signalling via cell 
membrane receptors such as integrins and dystroglycans.[6] 
Due to their involvement in the development of various tissues 
as a component of the BM, LMs were reported to promote the 
regeneration of muscle, skin, liver and nerves both in vitro and 
in vivo.[14,82–84]
To capitalise on these advantages and to form a tuneable 
system, we combine LM with PEG, a synthetic polymer whose 
structure allows to produce hydrogels with defined stiffness, as 
shown in Figure 2B,D,E. Furthermore, we note that tissue devel-
opment requires matrix remodeling by cells, that is conducted 
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by matrix-degrading enzymes like collagenase, trypsin, and 
other MMPs. Since PEG can only be degraded hydrolytically 
and not enzymatically, we show that the addition of protease-
degradable peptides can modulate the enzymatic degradability 
of the hydrogel (see Figure 1G). While developing hydrogels, we 
considered other parameters affecting degradation rate such as 
the mesh size and swelling properties of the hydrogel as shown 
in Figure 1F; and Figure S5, Supporting Information.[57]
Recent studies have used LM111 combined with PEG in a 3D 
hydrogel. For example, Francisco et  al. explored how soft, 3D 
LM111-functionalized hydrogels can promote the regeneration 
of the nucleus pulposus region of the intervertebral disc.[25,28] 
However, the authors did not take advantages of the versatility 
of LM isoforms, being able to bind different GFs in a tissue-
dependent manner.
Ishihara et al. showed that the covalent incorporation of an 
engineered GF-binding domain derived from LM, α2PI1–8-
LAMA33043–3067, in a 3D fibrin matrix, significantly enhanced 
the effect of VEGF-A165 and PDGF-BB on skin wound healing, 
by increasing GF retention into fibrin both in vitro and in 
vivo.[9] While this work set the concept of GF binding to LM at 
low doses, their approach included the use of a short fragment 
of LM’s alpha chain, without taking advantage of the full bio-
logical functions of the whole LM molecule.
Figure 5. LM/PEG enhances neurite growth in 3D. A) Schematic drawing of DRGs positioned in the spinal cord of a rat pup. B) Representative 
images of DRG cells in diverse culture conditions i–x): i) PEG+VPM hydrogel (HG) with no β-NGF added, ii) PEG+VPM hydrogel with 1 µg mL-1  
β-NGF added in the gel (HG+NGF), iii) PEG+VPM hydrogel with 0.5 µg mL-1 β-NGF supplemented media (HG+NGF m), iv) LM411/PEG+VPM hydrogel 
with no β-NGF added (HG), v) LM411/PEG+VPM hydrogel with 1 µg mL-1 β-NGF added in the gel (HG+NGF), vi) LM411/PEG+VPM hydrogel with 
0.5 µg mL-1 β-NGF supplemented media (HG+NGF m), vii) FN/PEG+VPM hydrogel with no β-NGF added (HG), viii) FN/PEG+VPM hydrogel with 
1 µg mL-1 β-NGF added in the gel (HG+NGF), ix) FN/PEG+VPM hydrogel with 0.5 µg mL-1 β-NGF supplemented media (HG+NGF m), x) Matrigel 
positive control. C) Neurite growth analysed by Neurite-J in three independent experiments (n = 3). Nmax represents the maximum number of neurites 
found in each sample. Each condition is represented by three replicates (mean ± SD, n = 3-individual experiments; ***p = 0.007 (PEG+VPM+NGF 
inside versus LM411/PEG+VPM+ NGF inside), *** p = 0.002 (LM411/PEG+VPM+NGF inside vs LM411/PEG + VPM+NGF media), *p = 0.1527 (LM411/
PEG+VPM+NGF inside vs FN/PEG+VPM+NGF). Scale bar = 500 µm.
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A more recent study[33] demonstrated the potential of a 
4-arm-PEG-Maleimide (PEGMAL) hydrogel modified with 
affinity-bound LM as a dynamic 3D platform enabling NSCs 
proliferation, neuronal differentiation, and neurite extension. 
The authors present a strategy to bind LM to a PEG backbone 
using agrin, a large proteoglycan that binds to LM through its 
N-terminal domain. Our approach, in turn, provides a robust 
and reliable system by covalently binding LM to the PEG net-
work and incorporating GFs that enhance cell growth and 
differentiation.
Here, we present a novel approach combining the different 
strategies discussed above to incorporate several LM isoforms 
(521, 332, and 411) as native, full-length proteins. PEGylated LM 
molecules are then covalently crosslinked to 3D PEG backbone 
for an efficient and long-term display and delivery of GFs to the 
resident cell population (BMP-2 and β-NGF) (Figure 4A).
Overall, the BMP-2 and β-NGF-sequestering systems devel-
oped in this study improve the activity and efficiency of GF 
delivery in reduced doses and prevent the need for their exog-
enous administration to guide stem cell fate and neurite out-
growth, as shown in Figures 4 and 5.
3. Conclusion
Here, we report the development and characterization of a 
platform based on hybrid 3D LM-PEG hydrogels with tuneable 
mechanical properties and degradability, as well as highly effi-
cient GF presentation for tissue regeneration of bone and nerve 
tissue. The LM/PEG hydrogels with GFs presented in this work 
introduce a flexible platform to engineer biomimetic microen-
vironments with tissue-specific biological and mechanical prop-
erties, with the potential to support the rational design of next 
generation in vitro tissue models.
4. Experimental Section
LM PEGylation: LMs (Biolamina AB), 100  µg mL-1) were PEGylated 
using PEG-AC-SCM (5 kDa, Laysan Bio, Inc). LM PEGylation was carried 
out to introduce functional AC groups to the protein. LM 411 (579 kDa, 
Biolamina AB), LM 521 (762  kDa, Biolamina AB), LM 332 (619kDa, 
Biolamina AB), and LM 111 (810  kDa, Trevigen Inc.) were PEGylated 
according to their respective molecular weights. The PEGylation 
(Figure 1C top) was done at a 1:25 molar ratio of LM to PEG-AC-SCM. 
The LMs came in a phosphate-buffered saline (PBS) solution at 
100 µg mL-1. Thus, 500 µl of the proteins were dialysed to change the 
buffer to sodium bicarbonate (NaHCO3; pH 8.5 as PEGylation takes 
place at this pH). To obtain the desired 1:25 molar ratio of AC to LM, 
calculated volumes of the Ac-PEG-NHS (1 mg mL-1 in PBS) were added 
to the respective LM solution and left to mix for 2 h at RT. Then, the 
solution was dialysed to remove all the unreacted acrylates and change 
the buffer to PBS for 1h at 4 °C. The LM PEGylated was stored at -20 °C 
for future use.
FN PEGylation: FN (YOProteins, 3 mg mL-1) was PEGylated as 
described by ref. [41]. FN was denatured in denaturing buffer (5 mm Tris[2-
carboxyethyl]phosphine hydrochloride [TCEP], pH 7, Sigma) and 8 m  
urea (Acros Organics, 99.5%) in phosphate buffer saline (PBS, Gibco, 
pH 7.4) for 15 min at RT. After that, (PEGMAL; 20 KDa, LaysanBio) was 
incubated for 30  min at room temperature at a molar ratio of 1:4 FN 
to PEGMAL. After obtaining PEGylated protein, non-reacted cysteine 
residues were blocked by alkylation using 14 mm iodoacetamide (Sigma) 
in PBS at pH = 8. Then, the product of the blocking reaction was dialysed 
in PBS for 1 h at RT. The dialysed protein solution was precipitated 
by adding 9 volumes of cold absolute ethanol to the protein solution. 
This was then mixed and incubated overnight at -20 °C. The next day, 
the protein solution was centrifuged at 15  000  g and 4 °C for 15  min. 
The supernatant was discarded and the pellet was washed once more 
in cold ethanol (90%) and centrifuged at 15 000 g and 4 °C for 5 min. 
Pellets were then dried and dissolved using 8 m urea to achieve a final 
protein concentration of 2.5 mg mL-1. Once the protein was dissolved, 
the solution was dialysed in PBS one last time and stored at -20 °C for 
future use.
3D LM/PEG Preparation: Different LM PEGylated isoforms 
were mixed with various amounts of 4-arm PEG-acrylate (PEG-
AC,10  kDa, Laysan Bio, Inc.), a protease degradable peptide 
cross-linker GCRDVPMSMRGGDRCG (VPM, 1.7  kDa, GenScript), 
and a photoinitiator (0.1% w/v Irgacure 2959, Sigma–Aldrich) to 
obtain degradable hydrogels with different stiffness. To from non-
degradable hydrogel, VPM volumes required were substituted with 
PEG dithiol (SH-PEG-SH, 2  kDa, Creative PEGWorks) as they have 
the similar molecular weight. The thiolated crosslinker was added 
at different molar ratio of acrylate:thiol (AC:VPM) such as 2:1, 1:1, 
and 1:2 to obtain hydrogels with various degradability. Subsequently, 
the hydrogel mixture was immediately pipetted into custom sterile 
polydimethylsiloxane (PDMS) molds (holes with 6  mm diameter 
and 3  mm thickness) and polymerised upon exposure to UV light 
(365  nm, Omnicure S1500, Excelitas Technologies, US) of power 
≈5  mW cm-2 for 6 min (Figure  1C bottom). Synthesised hydrogels 
were then transferred to sterile non-tissue culture treated plate wells. 
The nomenclature used in this paper is x % w/v LM (y)/PEG, x being 
the percentage of PEG used and y is the LM isoform incorporated 
inside of the hydrogel.
Rheology Measurements: A stress-controlled rheometer (MCR302, 
Anton Paar) equipped with a parallel plate geometry (upper plate 
diameter 15  mm; gel diameter 17.2  mm) at a temperature of 23 °C 
was used. Sample hydration was maintained during measurements by 
addition of PBS at the exposed sides of the specimens. A frequency 
sweep was performed prior to all experiments to determine the 
regime where the shear storage modulus, G’, was independent 
of frequency, ω; so that the shear modulus G of the gels could be 




).[47] Strain sweeps in the range of 0.01% to 
1% at an angular frequency of 10 rads-1, within the LVE regime of the 
gels, were performed and the shear modulus determined at a gap 
size corresponding to a normal force of ≈0.1 N for all gels reported in 
Figure  2. Additionally, a series of strain sweep tests were performed 
at different levels of compression: tests were performed by gradually 
varying the normal force applied to the unconfined samples (one strain 
sweep per level of compression), starting from a minimum force value 
of ≈0.1 N and with a minimal delay (i.e., of the order of a few seconds) 
between sequential compressions (Figure S3B, Supporting Information). 
In all tests, samples’ hydration was maintained by addition of PBS at the 
exposed sides of the specimens.
Nanoindentation Measurements: Nanoindentation measurements 
were performed using a nanoindentation device (Chiaro, Optics11) 
mounted on top of an inverted phase contrast microscope (Evos XL 
Core, Thermofisher) following a previously described approach.[85] 
Measurements were performed at RT in culture media. For each sample, 
single indentation curves (n > 22) were acquired at a speed of 2 µm s–1 
over a vertical range of 10  µm, changing the (x, y) point at every 
indentation. The selected cantilever had a stiffness of 0.032 Nm–1 
and held a spherical tip of 8.0 µm radius. The collected curves were 
analysed using a custom Python code.[86] Curves were first aligned 
using a baseline detection method based on the histogram of the 
force signal[87] and the corresponding indentation was calculated 
for each curve. The Hertz model (Equation (1) and Figure  2C) was 
fitted to the forward curve of the force (F)-indentation (δ) curve up 
to an indentation of about 10% of the tip radius (R), and the Young’s 
modulus (E) therefore extracted. The Poisson’s ratio (υ ) was assumed 
to be 0.5 as previously described.
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Release of GFs: To determine the mass percentage release of BMP-2 
(26  kDa, recombinant human bone morphogenetic growth factor, 
R&D Systems, Bio-Techne) from LM332/PEG hydrogels, BMP-2 was 
conjugated to with NHS-AlexaFluor-488 dye (10  µg mL-1, Gibco-Life 
Technologies) to allow its detection using a fluorescence plate reader. 
Synthesised hydrogels were transferred to individual centrifuge tube 
filters (Eppendorfs with filter units, Corning Costar spin-X) loaded 
with PBS as a releasing buffer. Over 5 days, the tubes containing the 
hydrogels loaded with BMP-2 were centrifuged at a rate of 8000  rpm 
for 10 min once per day. The supernatant was collected and stored at 
-20 °C and the filter units were reloaded with 400 µL of PBS. Ultimately 
the supernatant aliquots were pipetted into a black non-tissue culture 
treated plate and the fluorescence intensity of the GF released from 
the hydrogels was measured at 490  nm excitation and 510–570  nm 
emission wavelength using a microplate reader (Modulus II Microplate 
Multimode Reader, Turner BioSystems). The concentration of BMP-2 
in the samples was quantified using a standard curve, which relates 
fluorescence intensity to BMP-2 concentration, obtained from serial 
dilution of BMP-2 solutions.
MSCs Culture: Human bone marrow mesenchymal stem cells 
(hMSCs) (PromoCell GmbH, Germany) were expanded and maintained 
(Dulbecco’s modified Eagle medium (DMEM) (Sigma–Aldrich), 10% 
FBS (Sigma), 1% Sodium Pyruvate (11  mg mL–1, Sigma), 1% Gibco 
MEM NEAA (non-essential amino acids, Thermo Fisher Scientific), 2% 
antibiotic (6.74 U mL–1 penicillin–streptomycin (Sigma), and 0.2 µg mL–1 
fungizone) (Sigma). Media was changed every 3 days. When 80% cells 
were confluent, they were detached from the culture flask using Trypsin-
EDTA and spun down at 1400 rpm for 5 min. Cells were resuspended in 
PBS prior their encapsulation into the 3D hydrogels.
LIVE/DEAD Viability Assay: The viability of cells incorporated in LM/
PEG hydrogels was assessed with the LIVE/DEAD Viability/Cytotoxicity 
Assay Kit (Thermo Fisher Scientific, UK) using calcein and ethidium 
homodimer (EthD1). Calcein labeled live cells with green fluorescence, 
whereas EthD labelled dead cells with red fluorescence. LM/PEG 
hydrogels were synthesised as described earlier (with the concentration 
of hMSCs encapsulated being equivalent to 1 × 106 cells per mL). At each 
time point, gels were washed with PBS twice, and appropriate volumes 
of calcein (4  mm) and EthD (2  mm) were added. After staining, gels 
were left to incubate for 30 min at 37 °C. To determine the percentage 
of cells viable in the culture, gels were consequently imaged using a 
fluorescent microscope (Zeiss Axio Observer.Z1-Inverted Microscope, 
US) on days 1, 3, and 7. Images acquired were processed using Fiji 
software, to calculate the number of viable cells in relation to the total 
number of cells (%).
Cell Morphology: Cells were fixed with 4% paraformaldehyde (PFA) for 
15 min at RT and then permeabilized with 0.1% Triton X-100 for 10 min, 
before washing with PBS twice. After that, 1% bovine serum albumin 
(BSA, Sigma–Aldrich) in PBS was added to block non-specific antibody 
binding. Cell F-actin was labelled for 1 h incubation at RT with Alexa 
Fluor 488 Phalloidin (1:100, ThermoFisher) in blocking buffer. Nuclei 
were stained using Vectashield mounting medium with DAPI nuclear 
stain (Vector Laboratories). Samples were then washed in PBS three 
times. Z-stack imaging was performed using a Widefield microscope 
(Leica DMi8 Inverted Microscope) with a 40X/1.4 numerical aperture 
oil objective, and more than five images per condition of the three 
independent experiments were assessed using Fiji software to measure 
the cell morphology.
hMSCs Differentiation in 3D LM/PEG: Cell were encapsulated in LM/
PEG hydrogels (1 × 106 cells per mL, n  =  3) were incubated for 14 and 21 
days in OM at a ratio of AC: VPM of 1:2, that was exchanged every 3–4 days. 
OM was prepared by mixing DMEM expansion media, supplemented 
with 100 µmol ascorbic acid (Sigma), 100 nmol dexamethasone (Sigma), 
and 3mm sodium phosphate (Sigma). After culture, hydrogels were 
fixed in 4% (v/v) PFA in PBS for 20 min and washed in PBS there times. 
Then, samples were treated with 0.1% (v/v) Triton-X-100 and 0.1% (v/v) 
Tween-20 for 15 min at RT. Cells were incubated for 1h with the following 
antibodies: OPN (1:400, ab8448, Abcam) and OCN (1:50, sc-390877, 
Santa Cruz Biotechnology). Detection was performed using the following 
secondary antibodies: Cy3 goat anti-rabbit (1:100, 16870-AAT, Jackson 
ImmunoResearch – Stratech), Alexa Fluor 647 donkey anti-mouse 
(1:200, Invitrogen).Nuclei were visualized with DAPI (0.5  µg mL–1; 
D1306, Invitrogen) and F-actin with Alexa Fluor488 phalloidin 
(1:100 dilution, Invitrogen) incubated for 1h at RT. Z-stack imaging 
was performed using a Widefield microscope (Leica DMi8 Inverted 
Microscope) with a 63X/1.4 numerical aperture oil objective, and more 
than 30 cells from three independent experiments were assessed using 
Imaris software to quantify the mean intensity of the OPN and OCN.
Protein (OPN and OCN) Expression Quantification using Imaris: The 
Z-sections of the deconvolved images (20 slices) acquired from the 
widefield microscope were imported into Imaris 9.1.2 software (Bitplane 
AG, Zurich, Switzerland) and each part of the cell stained were quantified 
by 3D surface rendering. Briefly, the image display was adjusted for all of 
four channels (dapi, blue; phalloidin, green; OPN, red; OCN, magenta), 
and the rendering quality was set to 100%. Surfaces were created by 
selecting source channel and smooth surface detail set at 0.198  µm. 
Background subtraction was set to 0.743  µm, and the threshold was 
reduced for surfaces to fully cover all voxels. The surface area, volume 
of the surfaces, and mean intensity generated were quantified by Imaris 
for all the channels, and the values were exported into Excel for graphical 
and statistical analysis using GraphPad Prism. In certain cases, in the 
phalloidin channel, cells were in contact with each other, preventing 
an accurate rendering of individual cells and the quantification of their 
morphological parameters.
Quantitative Polymerase Chain Reaction with Reverse Transcription 
(qRT-PCR): Total RNA was extracted from MSCs cultured for 14 or 21 days 
under different experimental conditions using FastPrep Lysing Matrix 
D kit (MP biomedicals). Hydrogels were transferred into Lysing Matrix 
H tubes and 500 µl of trizol reagent (Invitrogen were added) on top of 
them. Then, the samples were homogenized in Lysing Matrix H tubes 
(MP Biomedicals, USA) on a FastPrep-24 (MP Biomedicals, 4.5 m s-1 for 
2 cycles of 20 s). 0.1 mL of chloroform was added to each tube, shaken 
vigorously, and incubated RT for 2 min. Samples were then centrifuged 
at 12  000  g for 5 min at 4 °C to separate each sample mixture into a 
lower phenol–chloroform and an upper aqueous phase. The aqueous 
phase was carefully aspirated from each sample and placed into a 
clean eppendorf tube to carry out RNA isolation. In the aqueous 
phase 5 µl of a 3  mg mL-1 of solution GlycoBlue (Thermo Fisher 
Scientific) solution was added to each sample followed by 250 µl of 
isopropanol. Glycoblue is a blue dye conjugated to glycogen. Glycogen 
is precipitated with RNA in alcohol and its addition serves as a means of 
visualising RNA by way of producing a blue pellet during the extraction 
procedure. Samples were mixed by inverting each tube lightly and then 
incubated RT for approximately 10 min. After incubation, samples 
were centrifuged at 12  000  g for 10 min at 4 °C. The supernatant was 
aspirated to waste and the pellet washed in 500 µl of 75% ethanol 
solution. Samples were then centrifuged at 7500  g for 5 min at 4 °C 
to draw down the pellet. The supernatant was aspirated to waste and 
the pellet allowed to air dry. The pellet was then resuspended in 15 µl 
of RNase free water and incubated for 10 min on a heat block set to 
55 °C to dissolve the RNA. Samples were stored at -80 °C until ready 
for use. RNA quantity and integrity were measured with a NanoDrop 
1000 (ThermoScientific). Then 100  ng of RNA were reverse transcribed 
using the Superscript III reverse transcriptase (Invitrogen) and oligo dT 
primer (Invitrogen). Real-time qPCR was performed using Sybr select 
master mix and 7500 Real Time PCR system from Applied Biosystems. 
The reactions were run at least in triplicate for both technical and 
biological replicas. The primers used for amplification were designed 
from sequences found in the GenBank database and included: Runx2 
(Forward: 5´-TGA GAG TAG GTG TCC CGC CT-3´, Reverse: 5´-TGT 
GGA TTA AAA GGA CTT GGT GC-3´) and OPN (Forward: 5´-TTT GCC 
TGT TTG GCA TTG C-3´, Reverse: 5´-TGG GTG CAG GCT GTA AAG 
CT3´) for osteogenic differentiation. GAPDH (Forward: 5´-GTG TGA 
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ACG GAT TTG GCC GT-3´, Reverse: 5´-TTG ATG TTA GTG GGG TCT 
CG-3´) was used as a housekeeping gene. The fractional cycle number 
at which fluorescence passed the threshold (Ct values) was used for 
quantification by the comparative Ct method. Sample values were 
normalized to the threshold value of housekeeping gene GAPDH: ΔCT = 
(experiments) - CT(GAPDH). The Ct value of the control was used as 
a reference. ΔΔCT  =  ΔCT(experiment) -  ΔCT(control). mRNA expression 
was calculated by the following: = −∆∆2 Tfoldchange C
Dorsal Root Ganglia: DRG cells were extracted from the isolated 
spine of P1 old rat pups. DRG cells were extracted from P1 rat pups 
as described by ref. [80]. P1 rat pups were donated from the Glial Cell 
Biology Group within the Institute of Infection and Immunity and 
Inflammation of the University of Glasgow. The provided tissue came 
from animal experiments carried out at the University of Glasgow, 
under projects approved by the Home Office in the UK. The spinal cord 
of each rat pup was isolated, and the adjacent tissues were removed. 
The spinal cord was cut in half in order to remove the cerebrospinal 
fluid. Each DRG was removed with sharp edged thumb forceps under a 
dissection microscope and collected in culture dishes. Dissected DRGs 
were placed in fresh Hank’s balanced salt solution (Sigma). The excess 
meninges and tissue debris were removed with tweezers and surgical 
scissors under a dissecting microscope. DRGs were collected in petri 
dishes and introduced to 3.5% w/v PEG+VPM, LM411/PEG+VPM and 
FN/PEG+VPM hydrogels at one DRG per gel on the same day before 
polymerisation with a 0.5  mm gauge needle. For DRG in 3D culture, 
media was changed every 3 days.
Immunofluorescence, Image Acquisition, and Analysis for DRGs: 
DRG hydrogels were fixed with 4% PFA at RT for 20 min and stained 
with anti-β3-tubulin (ab78078). 2D Images for analysis were taken 
at 5X for DRGs using brightfield and fluorescent microscopy (ZEISS 
Axio Observer.Z1). Images were analysed with Neurite-J plug-in for 
ImageJ software. Graphs and subsequent statistical analysis were 
performed using GraphPad Prism version 8.00 for Windows. For 
Nmax comparison between hydrogel conditions, one-way ANOVA 
was performed. A p value lower than 0.05 was considered significant. 
Data is represented as mean ± SD.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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